Modern drug discovery has typically focused on developing tools to design drugs that target a single disease-causing protein at a time. For complex diseases such as cancer, effective drugs must be designed to engage multiple disease proteins simultaneously. This is the approach taken by USA-based Harmonic Discovery, and wonderfully expressed in its name and logo. Designed by Studio Mast, four lines converge, harmonise and diverge to form an abstract ‘H’